Skip to main content
. 2010 Oct 15;2:144. doi: 10.3389/fnagi.2010.00144

Figure 3.

Figure 3

Benefits from reward anticipation in young healthy participants, healthy elderly, and Parkinson's patients (PD). (A) Average antisaccade onset latency was significantly faster on reward anticipation trials (red) than on trials where no reward was expected (blue). (B) Average antisaccade accuracy was significantly higher on reward anticipation trials (red) than when no reward was anticipated (blue). *P< 0.05; **P < 0.01.